The livestock diagnostics market is expected to grow at a CAGR of 7.8% from 2019 to 2027 to reach at $1.85 billion by 2027. Livestock diagnostics include consumables comprising of the test kits, reagents, and systems used to detect and diagnose diseases in livestock samples, such as blood, serum, urine, and stool. Livestock diagnosis has emerged as an essential part of disease management and prevention as it help in confirming the health status of animals and identifying pathogens. Thus, the early detection, management, and control of animal diseases helps to facilitate the safe trade of animals and animal products.
Here are the top 10 companies operating in Livestock Diagnostics Market-
IDEXX Laboratories, Inc.
IDEXX Laboratories is engaged in developing, manufacturing, and distributing products and providing services primarily for the companion animals, livestock including poultry and dairy, and water testing markets. The company operates through three segments, namely, Companion Animal Group (CAG), Water Quality Products (Water), and Livestock, Poultry and Dairy (LPD). The company operates in the livestock diagnostics market through its Livestock, Poultry and Dairy (LPD) segment and provides diagnostic tests and related instruments used to manage the health status of livestock and poultry. The company’s primary diagnostic products include tests for Bovine Viral Diarrhea Virus (BVDV) and Porcine Reproductive and Respiratory Syndrome (PRRS).
The company sells its products and services in more than 175 countries and has a direct presence through its manufacturing and R&D sites, and reference laboratories in the U.S., the U.K., Canada, Australia, New Zealand, Brazil, South Africa, France, Switzerland, the Netherlands, China, Spain, and Japan.
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific provides analytical instruments, laboratory equipment, lab services, and diagnostics instruments through five brands, namely, Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services. The company operates through four business segments, namely, Laboratory Products & Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company offers livestock diagnostic products, such as VetMAX kits, PrioCHECK kits, LSIVet kits, and PCR systems through its Specialty Diagnostics and Laboratory Products & Services segments.
The company’s Specialty Diagnostics business segment has a direct presence in the U.S. through its operational offices, engineering sites, and laboratories; and production sites which are present in Virginia, Kansas, Michigan, New Hampshire, and California, within the U.S., and in Sweden, Germany, the U.K., France, Switzerland, Finland, China, Canada, and Japan. While the Laboratory Products & Services business segment has its geographic presence through its production sites, operational offices, engineering sites, and laboratories across North Carolina, Pennsylvania, Ohio, Puerto Rico, New York, New Jersey, South Carolina, Illinois, and California, within the U.S., and in the U.K., Austria, Italy, Canada, France, Germany, and China.
bioMérieux manufactures in-vitro diagnostic solutions and is engaged in the development of new approaches in the field of diagnostics, immunotherapy, food safety, and nutrition to fight against infectious diseases and cancers. The company develops, manufactures, and markets systems that are used in industrial and clinical applications, such as clinical diagnostics, industrial microbiological control – particularly in the agri-food sector, environmental monitoring, veterinary diagnostics, microbial identification, and resistance detection. The company manufactures and offers a range of veterinary solutions, such as culture media, instruments such as VITEK, NUCLISENS easyMAG, and others to combat animal diseases through the Industrial Applications.
The company has a direct presence through its production and R&D sites in the U.S., Brazil, France, Spain, Italy, Australia, Germany, India, Belgium, and China and its subsidiaries in Kenya, the U.S, Norway, Serbia, Chile, Mexico, Brazil, Sweden, Argentina, Vietnam, Thailand, India, China, Canada, Turkey, Russia, Italy, Greece, Germany, Belgium, Singapore, Japan, the U.K., Australia, Spain, the Netherlands, and South Africa.
Zoetis is engaged in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products, primarily livestock and companion animals. The major product offerings of the company include vaccines, anti-infectives, parasiticides, other pharmaceutical products, dermatology products, medicated feed additives, animal health diagnostics, and others, including non-pharmaceutical product categories such as nutritional, agribusiness, biodevices, genetic tests, and precision livestock farming. The prominent end users of the company are veterinarians and livestock producers. The company offers its livestock diagnostic products, such as analyzers, consumables, and testing kits through its subsidiary Abaxis, Inc. (U.S.).
The company has its R&D operations along with manufacturing sites in Austria, Belgium, Brazil, China, Denmark, Spain, the U.S., Australia, Belgium, India, Vietnam, and Norway.
Bio-Rad Laboratoris, Inc.
Bio-Rad is engaged in the development, manufacture, and marketing of products used in life science research and clinical diagnosis. The products and solutions of the company are based on technologies to separate, purify, identify, analyze, and amplify biological materials such as cells, bacteria, antibodies, proteins, and nucleic acids. The company operates through two business segments, namely, Life Science and Clinical Diagnostics.
The company operates in the livestock diagnostics market through the Clinical Diagnostics segment, which designs, manufactures, and sells test systems, informatics systems, test kits, and specialized quality controls to several clinical diagnostic and reference laboratories. This segment offers livestock diagnostic products such as testing kits for swine and equine. The prominent end users of the company’s clinical diagnostic products are hospital, reference, transfusion, and physician office laboratories. The subsidiary of the company operating in the livestock diagnostics business is SafePath Laboratories, LLC (U.S.).
The company has a direct presence through its manufacturing, research, and distribution facilities, in the U.S., France, Switzerland, Germany, Belgium, Switzerland, and Singapore. The company also has its direct distribution channels in over 35 countries. The principal manufacturing and research facilities of the company for the Clinical Diagnostics segment is located in the U.S., Singapore, France, Switzerland, Germany, and Belgium. The subsidiary of the company operating in the livestock diagnostic business is SafePath Laboratories, LLC (U.S.).
A report into the projected growth of the current Livestock Diagnostics Market by Meticulous Research® has produced some incredible forecasts for the industry. By 2027, it’s expected to have grown at a CAGR of 7.8%, reaching over $1.85 billion.
Indical Bioscience, GMBH
Founded in 1996 and headquartered in Leipzig, Germany, INDICAL BIOSCIENCE, an animal health company funded by Fidelio Capital (Sweden), is a provider of molecular diagnostic workflows and protocols. The company offers diagnostic solutions, such as sample preparation kits, pathogen-specific PCR assays and ELISA kits, and high- to low-throughput testing instruments for protecting human and animal health. INDICAL operates in the livestock diagnostics market by providing assays and kits for detecting pathogens. The company offers its products to veterinarians, industries, and government agencies.
INDICAL has a local presence in 169 countries, a direct presence in 22 countries, and has more than 75 commercial partners for product distribution in 147 countries. In April 2018, QIAGEN N.V. (Netherlands) transferred its veterinary assays business to INDICAL BIOSCIENCE after which the company is operating as an independent provider of veterinary solutions.
Founded in 1975 and headquartered in Scarmagno, Italy, Agrolabo manufactures and distributes nutritional, diagnostic, and therapeutic products for livestock and companion animals. The company has developed new lines of diagnostic products providing the tools for accurate diagnostic investigations, from dermatology, hematology, to infectious diseases. The company operates through five divisions, namely, Animal Husbandry, Cavalli, Diagnostics, Industry, and Bio-Energy. The company offers diagnostic test kits for the detection of infectious diseases in companion and livestock animals through the Diagnostics division and for equine animals through the Cavalli division.
The company’s livestock products are manufactured using the ELISA, Microbiology, Immunofluorescence, Immunochromatography, and PCR & RT-PCR technologies. The company’s diagnostic products are distributed worldwide.
Neogen Corporation is a manufacturer of products dedicated to food and animal safety and operates through two reportable segments, namely, Food Safety and Animal Safety. The Food Safety segment is engaged in the development, production, and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, and levels of general sanitation. The company operates in the livestock diagnostics market through its Animal Safety segment, which develops, produces, and markets products dedicated to animal safety. The company’s animal safety products include veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services. The company’s livestock diagnostic products portfolio includes pregnancy and virus detection testing for bovine and swine applications.
The company has international operations across the U.K., Mexico, Brazil, Canada, China, India, Scotland, the U.K., and Australia. The company has genomics laboratories in the U.S., the U.K., Brazil, and Australia.
Founded in 2004 and headquartered in Grabels, France, IDvet develops and manufactures diagnostic tests for the detection of infectious diseases in farm animals. The company develops products, such as reagents for both emerging and established diseases using the RT-PCR and ELISA technology. The company operates in the livestock diagnostics market by offering disease testing kits and reagents for animals, such as ruminants, swine, avian, and equine.
The company exports its veterinary diagnostic products to over 80 countries like Australis, Belgium, Bangladesh, China, Brazil, Greece, Egypt, France, Korea, Mexico, Spain, South Africa, the U.K., the U.S, and others.
GD Animal Health
Founded in 1919 and headquartered in Overijssel, Netherlands, GD Animal Health is a leading organization in animal health and animal production. The company offers various consumables, such as antigens, monospecific antisera, and reference sera to monitor the health and diagnose diseases in animals such as cattle, poultry, swine, horses, and others. The company combines monitoring and eradication of diseases with practical research projects to identify emerging diseases and develop new laboratory tests. The adopts technologies such as Hemagglutination Inhibition (HI), Agar Gel Precipitation (AGP), ELISA, and PCR.
The company has its presence in eastern and central Europe, Egypt, Indonesia, Ireland, India, Ethiopia, Russia, and Finland. At the veterinary laboratory of the company in Deventer, almost five million laboratory tests are carried out every year.
Authoritative Research on the Livestock Diagnostics Market – Global Opportunity Analysis and Industry Forecast (2019-2027)
Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.
Please download report pages and learn more: